Previous 10 | Next 10 |
home / stock / seovf / seovf news
(TheNewswire) Confirms Ongoing Safety and Tolerability of Sernova’s Cell Pouch LONDON, ONTARIO – TheNewswire - March 17, 2022 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical- stage company and leader in regenerative medicine cell the...
(TheNewswire) Sernova awarded top performer status for two years standing LONDON, ONTARIO – February 24, 2022 – Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage regenerative medicine and cell therapy therapeutics company focus...
(TheNewswire) Sernova prepares for clinical trial of new treatment for post-operative hypothyroidism LONDON, ONTARIO - TheNewswire – January 27, 2022 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH), a clinical-stage regenerative medicine an...
(TheNewswire) LONDON, ONTARIO – TheNewswire - January 20, 2022 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH), a clinical-stage regenerative medicine and cell therapy therapeutics company developing a potential ‘functional cure’ for ...
(TheNewswire) LONDON, ONTARIO - TheNewswire - January 10, 2022 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH), a clinical-stage regenerative medicine and cell therapy therapeutics company developing a potential ‘functional cure’ for type 1 diabet...
(TheNewswire) LONDON, ONTARIO – TheNewswire - January 5, 2022 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH), a clinical-stage regenerative medicine and cell therapy therapeutics company focused on developing a potential ‘functional cure...
(TheNewswire) LONDON, ONTARIO - TheNewswire – December 16, 2021 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH), a clinical-stage regenerative medicine and cell therapy therapeutics company focused on developing a potential ‘functional cure&...
(TheNewswire) LONDON, ONTARIO - TheNewswire - December 14, 2021 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH), a clinical-stage leader in regenerative medicine and cell therapy therapeutics developing a potential ‘functional cure’ for type...
(TheNewswire) LONDON, ON - TheNewswire - December 2 , 2021 - Sernova Corp . (TSXV:SVA) (FSE/XETRA:PSH)(OTC:SEOVF), a leading clinical-stage company focused on regenerative medicine therapeutics, is pleased to announce that ...
(TheNewswire) LONDON, ON - TheNewswire – November 16 , 2021 -- Sernova Corp . (TSXV:SVA)(FSE/XETRA:PSH)(OTC:SEOVF), a leading clinical-stage company focused on regenerative medicine therapeutics, today announced that Dr. P...
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) To date Sernova reports 7 patients in its Phase I/II type 1 diabetes clinical trial achieved freedom from insulin injections and demonstrate blood sugar control in the non- diabetic range (HbA1c 6.5%); 6 patients have reached between 5.5 and 50 months o...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – June 12, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatmen...
Orbital Infrastructure Group Inc. (OIGBQ) is expected to report for Q1 2024 OFS Credit Company Inc. (OCCI) is expected to report for Q2 2024 KBC Groupe NV ADR (KBCSY) is expected to report for Q1 2024 Daikin Industries Ltd ADR (DKILY) is expected to report $0.11 for Q4 2024 Invita...